ADVERTISEMENT
2 /3 FREE ARTICLES LEFT THIS MONTH Remaining
Chemistry matters. Join us to get the news you need.

If you have an ACS member number, please enter it here so we can link this account to your membership. (optional)

ACS values your privacy. By submitting your information, you are gaining access to C&EN and subscribing to our weekly newsletter. We use the information you provide to make your reading experience better, and we will never sell your data to third party members.

ENJOY UNLIMITED ACCES TO C&EN

Outsourcing

Piramal and Ampac invest in pharmaceutical chemical plants

by Michael McCoy
June 29, 2019 | APPEARED IN VOLUME 97, ISSUE 26

 

Two pharmaceutical chemical makers have upgraded recently acquired facilities. Piramal Pharma Solutions put $10 million into the Riverview, Michigan, facility it got when it acquired Ash Stevens in 2016. The investment expands Piramal’s ability to produce high-potency active pharmaceutical ingredients. Ampac Fine Chemicals, meanwhile, has reopened the Petersburg, Virginia, facility it acquired in 2016 from Boehringer Ingelheim. Ampac says it has upgraded technology and refreshed infrastructure.

X

Article:

This article has been sent to the following recipient:

Leave A Comment

*Required to comment